Projects funded by the NCN
TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic opportunities
2025/57/N/NZ4/04486
Keywords:
alternative splicing mutant p53 FGFR1 targeted therapy synthetic lethality
Descriptors:
- NZ4_12:
- NZ7_08:
- NZ2_04:
Panel:
NZ4 - Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution :
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 24 - announced on 2025-03-17
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2026-01-20
Project end date (Y-m-d): 2029-01-19
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.